IMRX
Price
$1.25
Change
+$0.06 (+5.04%)
Updated
May 1, 10:48 AM (EDT)
Capitalization
42.1M
12 days until earnings call
SRRK
Price
$32.42
Change
-$0.49 (-1.49%)
Updated
May 1, 11:13 AM (EDT)
Capitalization
3.12B
7 days until earnings call
Ad is loading...

IMRX vs SRRK

Header iconIMRX vs SRRK Comparison
Open Charts IMRX vs SRRKBanner chart's image
Immuneering
Price$1.25
Change+$0.06 (+5.04%)
Volume$1.98K
Capitalization42.1M
Scholar Rock Holding
Price$32.42
Change-$0.49 (-1.49%)
Volume$100
Capitalization3.12B
IMRX vs SRRK Comparison Chart
Loading...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRX vs. SRRK commentary
May 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRX is a StrongBuy and SRRK is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 01, 2025
Stock price -- (IMRX: $1.19 vs. SRRK: $32.91)
Brand notoriety: IMRX and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRX: 410% vs. SRRK: 109%
Market capitalization -- IMRX: $42.1M vs. SRRK: $3.12B
IMRX [@Biotechnology] is valued at $42.1M. SRRK’s [@Biotechnology] market capitalization is $3.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $294.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRX’s FA Score shows that 0 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • IMRX’s FA Score: 0 green, 5 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, SRRK is a better buy in the long-term than IMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRX’s TA Score shows that 4 TA indicator(s) are bullish while SRRK’s TA Score has 5 bullish TA indicator(s).

  • IMRX’s TA Score: 4 bullish, 5 bearish.
  • SRRK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SRRK is a better buy in the short-term than IMRX.

Price Growth

IMRX (@Biotechnology) experienced а -15.60% price change this week, while SRRK (@Biotechnology) price change was +1.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.47%. For the same industry, the average monthly price growth was +7.86%, and the average quarterly price growth was -7.71%.

Reported Earning Dates

IMRX is expected to report earnings on Aug 06, 2025.

SRRK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+2.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($3.12B) has a higher market cap than IMRX($42.1M). SRRK YTD gains are higher at: -23.855 vs. IMRX (-45.909). IMRX has higher annual earnings (EBITDA): -63.69M vs. SRRK (-250.12M). SRRK has more cash in the bank: 437M vs. IMRX (36.1M). IMRX has less debt than SRRK: IMRX (4.16M) vs SRRK (65.1M). IMRX (0) and SRRK (0) have equivalent revenues.
IMRXSRRKIMRX / SRRK
Capitalization42.1M3.12B1%
EBITDA-63.69M-250.12M25%
Gain YTD-45.909-23.855192%
P/E RatioN/AN/A-
Revenue00-
Total Cash36.1M437M8%
Total Debt4.16M65.1M6%
FUNDAMENTALS RATINGS
SRRK: Fundamental Ratings
SRRK
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
71
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMRXSRRK
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.860.60
+2.20%
GameStop Corp
AAPL212.501.29
+0.61%
Apple
SPY554.540.22
+0.04%
SPDR® S&P 500® ETF
BTC.X94207.310000-77.476560
-0.08%
Bitcoin cryptocurrency
TSLA282.16-9.87
-3.38%
Tesla

IMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with SPRB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
-19.05%
SPRB - IMRX
52%
Loosely correlated
-4.58%
NUVL - IMRX
42%
Loosely correlated
+1.16%
SRRK - IMRX
31%
Poorly correlated
+0.43%
ENTBF - IMRX
31%
Poorly correlated
N/A
INSM - IMRX
30%
Poorly correlated
+0.84%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with ONCY. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then ONCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
+0.43%
ONCY - SRRK
41%
Loosely correlated
-3.56%
PLRX - SRRK
40%
Loosely correlated
+7.43%
SNDX - SRRK
39%
Loosely correlated
+3.28%
VTGN - SRRK
39%
Loosely correlated
+2.18%
ALT - SRRK
37%
Loosely correlated
+2.94%
More